ImmuCell Corporation logo
ImmuCell Corporation ICCC
€ 5.59 -1.23%

Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025

report update icon

ImmuCell Corporation Kurzfristige Verbindlichkeiten 2011-2026 | ICCC

Kurzfristige Verbindlichkeiten Jährlich ImmuCell Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.41 M 4.2 M 3.07 M 2.53 M 2.21 M 2.5 M 2.57 M 2.06 M 2.06 M 818 K 1.01 M 636 K 666 K 635 K

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
4.41 M 635 K 2.1 M

Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Kurzfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
AbbVie AbbVie
ABBV
43.3 B $ 212.08 0.45 % $ 375 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 3.29 -1.94 % $ 983 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
6.18 M - 10.36 % $ 9.8 M usaUSA
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
66.3 M - -6.81 % $ 3.04 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
bluebird bio bluebird bio
BLUE
200 M - - $ 546 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
70.6 M - - $ 789 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
89.9 M $ 12.29 -11.96 % $ 1.86 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
BioDelivery Sciences International BioDelivery Sciences International
BDSI
82.4 M - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
25.6 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
63 M - - $ 3.74 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
3.8 M $ 1.08 -1.38 % $ 22.2 M israelIsrael
Enochian Biosciences Enochian Biosciences
ENOB
29.2 M - - $ 40.5 M usaUSA
Summit Therapeutics Summit Therapeutics
SMMT
73 M $ 16.55 -4.11 % $ 12.4 B britainBritain
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
1.47 B $ 319.85 -2.53 % $ 41.9 B usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
6.01 M $ 4.34 -2.47 % $ 832 M canadaCanada
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
31 M - - $ 384 M britainBritain
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
14 M - -10.95 % $ 876 K usaUSA
Fusion Pharmaceuticals Fusion Pharmaceuticals
FUSN
16.2 M - - $ 1.41 B canadaCanada